Crossmark

METRNL mitigates oxidative stress and inflammatory drawbacks in ovalbumin/lipopolysaccharide-induced allergic airway diseases via the IKK/IκB/NF-κB signaling pathway

Crossref DOI link: https://doi.org/10.1007/s00210-025-04070-6

Published Online: 2025-04-17

Published Print: 2025-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Khodir, Suzan A. https://orcid.org/0000-0002-2535-9445
Shaban, Anwaar M. https://orcid.org/0000-0001-7290-2642
Sweed, Eman https://orcid.org/0000-0003-3689-2648
El-aziz, Noha M. Abd

Mostafa, Basma Abdelnaby https://orcid.org/0009-0007-4513-9427
Latif, Asmaa A. Abdel https://orcid.org/0000-0003-0398-9371
El-Kalshy, Mai M.

Elgizawy, Eman I. https://orcid.org/0000-0002-8105-2480
Funding

Funding for this research was provided by:

Minufiya University
License Information

Text and Data Mining valid from 2025-04-17

Version of Record valid from 2025-04-17
More Information

Article History

Received: 24 January 2025

Accepted: 17 March 2025

First Online: 17 April 2025

Declarations

:

: The authors declare that they have not used artificial intelligence (AI)-tools for writing the manuscript.

: The ethics committee of the faculty of medicine, Menoufia University Menoufia, Egypt, with approval code 8/2024BIO, approved the study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below